Explore 3 Stock Ideas & Industry Insights Download Free Report

Think Research Corporation

Company price
0.315 CAD 0.00(0%)
Last update at 2024-04-22T15:11:00Z
VOLUME
15057
Market Cap
18.12M

Momentum Score

…

Think Research Corporation provides knowledge-based digital health software solutions in Canada, the United States, and internationally. The company's products portfolio comprises order sets that structures clinical pathway at the point of care; eReferrals that allows physicians to find and refer specialists directly from EMR systems; Digital Front Door, a patient engagement platform that enables healthcare organizations to provide access to care and health information through a single digital service window; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eForms, a real-time analytics to track resident volumes, signature adherence, and compliance; and COVID-19 clinical tools, as well as clinical support tools for long-term care. Think Research Corporation is based in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.32
Low
0.32
High
52 Week Price Range
0.15
Low
0.69
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.32
Dividend Yield
-
Revenue TTM
85.09M
Revenue Per Share
1.14
Gross Profit TTM
6.20M
Debt / Equity
-
ROE
-49.26%
Net Debt
32.72M
ROCE
-31.53%
Diluted EPS TTM
-0.21

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Income before tax -27.91M -30.51M -10.04M - -
Net income -25.74M -29.05M -10.02M - -
Selling general administrative 36.05M 31.66M 14.38M - -
Gross profit 37.39M 24.40M 11.93M - -
Reconciled depreciation 14.40M 7.99M 1.96M - -
Ebit - -24.14M -12.61M -11.84M -12.83M
Ebitda -9.52M -20.47M -6.60M - -
Operating income -19.84M -21.82M -8.86M - -
Interest expense 3.98M 2.05M 1.49M 0.00M 0.00M
Tax provision -2.16M -1.46M -0.02M - -
Net interest income -3.98M -2.05M -1.49M - -
Income tax expense - - -0.02M 0.01M -
Total revenue 78.60M 47.79M 19.44M - -
Total operating expenses 98.45M 69.61M 28.30M - -
Cost of revenue 41.22M 23.39M 7.51M - -
Total other income expense net -4.09M -6.64M 0.30M - -
Net income from continuing ops -25.74M -29.05M -10.02M - -
Net income applicable to common shares - - -10.02M -13.28M -12.43M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Total assets 122.88M 136.03M 12.22M - -
Intangible assets 34.03M 41.40M 0.38M - -
Other current assets 2.95M 3.73M 3.00M - -
Total liab 88.08M 86.12M 25.59M - -
Total stockholder equity 34.80M 49.91M -13.37M - -
Other current liab 7.50M 22.28M 5.28M 12.23M 12.13M
Common stock - - 64.17M 51.09M 38.15M
Capital stock 172.32M 164.82M 64.17M - -
Retained earnings -147.57M -121.82M -79.61M -69.06M -55.43M
Other liab - - 0.51M 0.68M 0.21M
Good will 47.38M 45.54M 0.53M - -
Other assets - - 0.13M - -
Cash 3.42M 6.32M 1.38M - -
Total current liabilities 59.95M 37.11M 19.62M 20.55M 18.32M
Net debt 32.72M 20.54M 6.97M - -
Short long term debt 25.32M 0.00M 8.35M - -
Other stockholder equity - - 0.09M 0.29M 0.05M
Property plant equipment - - 2.96M 0.49M 1.01M
Total current assets 20.66M 25.77M 8.21M 8.57M 8.48M
Net tangible assets - - -14.28M -16.95M -14.54M
Net receivables 12.76M 15.51M 3.83M 6.33M 3.19M
Long term debt 10.82M 26.86M - - -
Accounts payable 13.22M 12.02M 3.73M 1.54M 3.41M
Non current assets total 102.22M 110.26M 4.00M - -
Capital lease obligations 10.36M 12.38M 2.94M - -
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Investments -4.54M -27.38M -0.40M - -
Change to liabilities - -1.86M -5.20M -1.57M 5.06M
Total cashflows from investing activities - - -0.40M -0.18M -0.69M
Net borrowings - - 0.98M 3.72M 1.24M
Total cash from financing activities 6.38M 34.31M 8.25M 12.86M 9.94M
Change to operating activities - 5.67M -2.57M -0.19M -0.04M
Net income -25.74M -29.05M -10.02M -13.28M -12.43M
Change in cash -2.91M -4.55M -0.43M -3.24M 3.51M
Begin period cash flow 6.32M 10.88M 1.81M - -
End period cash flow 3.42M 6.32M 1.38M 1.81M -
Total cash from operating activities -4.75M -11.48M -8.28M -15.92M -5.74M
Issuance of capital stock - 12.92M 9.50M - -
Depreciation 14.40M 6.58M 1.96M 0.35M 0.54M
Dividends paid 0.00M 0.00M 0.54M 0.40M 0.22M
Change to account receivables 0.47M -2.49M 2.36M -2.87M -0.07M
Sale purchase of stock - 0.00M -0.50M - -
Other cashflows from financing activities - -3.04M -1.78M 0.98M -0.39M
Change to netincome - - 5.18M 1.63M 1.19M
Capital expenditures 4.17M 3.08M 0.05M 0.18M 0.69M
Change in working capital -0.26M 1.33M -5.41M - -
Stock based compensation 4.48M 7.25M 4.25M - -
Other non cash items 4.54M 1.83M 0.96M - -
Free cash flow -8.92M -14.56M -8.33M - -

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
THNK
Think Research Corporation
-
-%
0.32 - - 0.21 0.60 0.75 109.93
NURS
Hydreight Technologies Inc
0.01
0.36%
2.82 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc
0.01
2.82%
0.36 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 72.08 -0.81

Profile*

Think Research Corporation

Think Research Corporation provides knowledge-based digital health software solutions in Canada, the United States, and internationally. The company's products portfolio comprises order sets that structures clinical pathway at the point of care; eReferrals that allows physicians to find and refer specialists directly from EMR systems; Digital Front Door, a patient engagement platform that enables healthcare organizations to provide access to care and health information through a single digital service window; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eForms, a real-time analytics to track resident volumes, signature adherence, and compliance; and COVID-19 clinical tools, as well as clinical support tools for long-term care. Think Research Corporation is based in Toronto, Canada.

351 King St East, Toronto, ON, Canada, M5A 0L6

416 977 1955

Name Title Year Born
Mr. Sachin Aggarwal CEO & Director NA
Ms. Joanna Carroll Chief Admin. Officer NA
Mr. John Joseph Hayes C.A., CPA, M.B.A. Chief Financial Officer NA
Mr. Patrick Craib Chief Operating Officer NA
Mr. Saurabh Mukhi Chief Technology Officer NA
Mr. Michael G. Stewart Gen. Counsel & Corp. Sec. NA
Ms. Brynne Eaton-Auvaa MD of Clinical Connectivity & Chief of Staff NA
Mr. Mark Sakamoto Exec. VP NA
Ms. Janet Kimura MD & Exec. VP of Clinical Content and Education NA
Ms. Anna Taylor Managing Director of BioPharma Services NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…